Mucosal immunity in human and simian immunodeficiency lentivirus infections
about
Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical ResearchMetagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host MicrobiomeGut Microbiota in HIV Infection: Implication for Disease Progression and ManagementChallenges in mucosal HIV vaccine development: lessons from non-human primate modelsThe loss of CCR6+ and CD161+ CD4+ T-cell homeostasis contributes to disease progression in SIV-infected rhesus macaques.Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses.Immunity to HIV in Early LifeEffects of HIV-1 Tat on enteric neuropathogenesis.Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trialAltered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.Stability of the gorilla microbiome despite simian immunodeficiency virus infection.High expression levels of BLyS/BAFF by blood dendritic cells and granulocytes are associated with B-cell dysregulation in SIV-infected rhesus macaques.Fluctuations in Blood Marginal Zone B-Cell Frequencies May Reflect Migratory Patterns Associated with HIV-1 Disease Progression Status.Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus.Longitudinal Examination of the Intestinal Lamina Propria Cellular Compartment of Simian Immunodeficiency Virus-Infected Rhesus Macaques Provides Broader and Deeper Insights into the Link between Aberrant MicroRNA Expression and Persistent Immune AcDestabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees.Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionInside Out: HIV, the Gut Microbiome, and the Mucosal Immune System.Long-term efficient control of SIV infection in macaques is associated with an intact intestinal barrier.Esophageal Mucosa in HIV infection: A "deeper" look at this little spoken organ.Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune ActivationCCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals.Shedding of Oral Poliovirus Vaccine (OPV) by HIV-Infected and -Uninfected Mothers of OPV-Vaccinated Zimbabwean Infants.MAIT cells are depleted early but retain functional cytokine expression in HIV infection.Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients.Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrhea.Intestinal barrier dysfunction and microbial translocation in HIV-infected pregnant women is associated with preterm birth.
P2860
Q26765018-CBAB544F-60B7-4C62-B3B6-BD235192B4C6Q26779142-B76CC826-572A-4EA8-A00D-2474288EC8FBQ27014742-3AC18E78-3393-478F-A504-19125B39CF14Q27022152-652C56E6-9447-46D3-97D9-D59DD1E2FFB1Q33808773-D9536EB5-A63C-4AB0-B6C2-B72ADC9E1EB6Q33842408-A2D2054C-1F9F-40E8-9E0C-31D9BB001B91Q34033051-1798AD7D-DAD3-4A95-83B4-8B997DB71F6FQ34383417-AFBDF000-97F3-4485-AD6A-A934811E5E56Q34513477-00E46A36-FD28-4FEB-BA74-76E4972540DDQ34517656-00431847-D8E7-43CF-9496-E1A620BB0593Q34995811-BBCB54BB-698C-4878-9B19-10ADB7695B30Q35672894-041E0C27-63C7-4691-9E3C-30D63E5FAC9DQ36023880-D9370979-60F2-4E73-BE8C-E5C8522DB82AQ36132003-4B494F5D-6560-4715-94F6-1F68C31F4570Q36878906-B17EEA15-D694-481D-9E6F-477CD5F9AC4DQ36878937-E065501C-AE03-4ACD-A2CF-D3E8039450A1Q37014250-A3C8976B-430C-4839-B9AD-2AF675E52C0DQ38749963-D9AEA920-9681-470D-89D2-CA69911EF737Q39030604-4AC031D8-8395-48B3-B560-6A9981254269Q40106503-D84008EA-2301-430E-AB15-7FD46181462CQ40260767-677CE309-E46A-48A7-829C-00B09C4598D4Q40625213-FB194808-9073-49B1-B30E-072CEBCA99E7Q40789003-A95967CE-4EB0-42C3-80C4-02BEABFF7103Q40835562-40042547-D29E-4DEE-A763-AC31F98A761BQ41687115-0334EA70-DB4B-4A62-B9ED-59A3FC3C8588Q42208838-E1C5A3E3-E77E-48AD-8992-F7222C038F52Q46439906-55AC0B45-0274-4922-8A52-314B09AD52E4Q54246777-D9A52562-9152-4493-BF35-E2F1C266A95F
P2860
Mucosal immunity in human and simian immunodeficiency lentivirus infections
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mucosal immunity in human and simian immunodeficiency lentivirus infections
@ast
Mucosal immunity in human and simian immunodeficiency lentivirus infections
@en
Mucosal immunity in human and simian immunodeficiency lentivirus infections
@nl
type
label
Mucosal immunity in human and simian immunodeficiency lentivirus infections
@ast
Mucosal immunity in human and simian immunodeficiency lentivirus infections
@en
Mucosal immunity in human and simian immunodeficiency lentivirus infections
@nl
prefLabel
Mucosal immunity in human and simian immunodeficiency lentivirus infections
@ast
Mucosal immunity in human and simian immunodeficiency lentivirus infections
@en
Mucosal immunity in human and simian immunodeficiency lentivirus infections
@nl
P2860
P356
P1433
P1476
Mucosal immunity in human and simian immunodeficiency lentivirus infections
@en
P2093
J M Brenchley
P2860
P2888
P304
P356
10.1038/MI.2013.15
P577
2013-04-03T00:00:00Z
P5875
P6179
1039628250